Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability

References

• Yatham L, Kennedy S, Parikh S, et al. The evolution of CANMAT bipolar disorder guidelines : past, present, and future. Bipolar Disord. 2013;15:58–60.
   PubMedGoogle Scholar
• Tondo L, Vázquez GH, Baldessarini RJ. Depression and mania in bipolar disorder. Curr Neuropharmacol. 2017;15:353–358.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Harrow M. Bipolar disorder: clinical course and outcome. American Psychiatric Pub, 1999.
   Google Scholar
• Treuer T, Tohen M. Predicting the course and outcome of bipolar disorder : A review. Eur Psychiatry. 2010;25:328–333.
   PubMed Web of Science ®Google Scholar
• Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry. 2006;11:227–240.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (UK). Bipolar disorder: assessment and management [Internet]; 2014. Available from: nice.org.uk/guidance/cg185%0A©.
   Google Scholar
• Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378:1306–1315.
   PubMed Web of Science ®Google Scholar
• Mazza M, Marano G, Traversi G, et al. Cariprazine in bipolar depression and mania: state of the art. CNS Neurol Disord Drug Targets. 2018;17:723–727.
   PubMed Web of Science ®Google Scholar
• Vieta E, Berk M, Wang W, et al. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord. 2009;119:22–27. Available from: http://www.sciencedirect.com/science/article/pii/S0165032709000974
   PubMed Web of Science ®Google Scholar
• Bond DJ, Noronha MM, Kauer-Sant’Anna M, et al. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry. 2008;69:1589–1601. Available from: http://europepmc.org/abstract/MED/19192442
   PubMed Web of Science ®Google Scholar
• Allain F, Minogianis EA, Roberts DCS, et al. How fast and how often: the pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev. 2015;56:166–179. Available from: http://dx.doi.org/10.1016/j.neubiorev.2015.06.012
   PubMed Web of Science ®Google Scholar
• Viktorin A, Lichtenstein P, Thase ME, et al. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry. 2014;171:1067–1073.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Rapport DJ, Kimmel SE, et al. Controlled trials in bipolar I depression : focus on switch rates and efficacy. Eur Neuropsychopharmacol. 1999;9:109–112.
   PubMed Web of Science ®Google Scholar
• Goldberg J, Perlis RH, Ghaemi S, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;164:1348–1355.
   PubMed Web of Science ®Google Scholar
• Mazzarini L, Colom F, Pacchiarotti I, et al. Psychotic versus non-psychotic bipolar II disorder. J Affect Dis. 2010;126:55–60.
   PubMed Web of Science ®Google Scholar
• Bora E, Yucel M, Pantelis C, et al. Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatr Scand. 2011;123:165–174.
   PubMed Web of Science ®Google Scholar
• Kelly T. Is donepezil useful for improving cognitive dysfunction in bipolar disorder? J Affect Disord. 2008;107:237–240.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GUYM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders : update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10:85–116.
   PubMed Web of Science ®Google Scholar
• Goldberg J, Perlis R, Ghaemi S, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;64:1348–1355.
   Google Scholar
• Loo C, Katalinic N, Mitchell PB, et al. Physical treatments for bipolar disorder : a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord. 2011;132:1–13.
   PubMed Web of Science ®Google Scholar
• Dolberg OT, Dannon PN, Schreiber S, et al. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord. 2002;4(Suppl 1):94–95.
   PubMedGoogle Scholar
• Tamas RL, Menkes D, El-Mallakh RS. Stimulating research : a prospective, randomized, controlled study of slow transcranial magnetic stimulation in depressed bipolar patients. J Neuropsychiatry Clin Neurosci. 2007;19:303–304.
   Web of Science ®Google Scholar
• Tavares DF, Myczkowski ML, Alberto RL, et al. Treatment of bipolar depression with deep TMS: results from a double-blind, randomized, parallel group, sham-controlled clinical trial. Neuropsychopharmacology. 2017;42:2593–2601.
   PubMed Web of Science ®Google Scholar
• Mutz J, Edgcumbe DR, Brunoni AR, et al. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: a systematic review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev. 2018;92:291–303.
   PubMed Web of Science ®Google Scholar
• Dondé C, Neufeld NH, Geoffroy PA. The impact of transcranial direct current stimulation (tDCS) on bipolar depression, mania, and euthymia : a systematic review of preliminary data. Psychiatr Q. 2018;89:855–867.
   PubMed Web of Science ®Google Scholar
• Dondé C, Amad A, Nieto I, et al. Transcranial direct-current stimulation (tDCS) for bipolar depression: A systematic review and meta-analysis clément. Prog Neuropsychopharmacol Biol Psychiatry 2017; Available from: http://dx.doi.org/10.1016/j.pnpbp.2017.05.021.
   PubMed Web of Science ®Google Scholar
• Xia G, Gajwani P, Munzina D, et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2008;11:119–130.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Hoy KE, Elliot D, et al. A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression. J Affect Disord. 2016;198:158–162.
   PubMed Web of Science ®Google Scholar
• Hu S, Lai J, Xu D, et al. Efficacy of repetitive transcranial magnetic stimulation with quetiapine in treating bipolar II depression : a randomized, double-blinded, control study. Sci Rep. 2016;6:1–7.
   PubMedGoogle Scholar
• Nahas Z, Kozel FA, Li X, et al. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003;5:40–47.
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Mundo E, D’Urso N, et al. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord. 2009;11:76–81.
   PubMed Web of Science ®Google Scholar
• Rachid F. Repetitive transcranial magnetic stimulation and treatment-emergent mania and hypomania: a review of the literature. J Psychiatr Pract. 2017;23:150–159.
   PubMed Web of Science ®Google Scholar
• Anand S, Hotson J. Transcranial magnetic stimulation: neurophysiological applications and safety. Brain Cogn. 2002;50:366–386.
   PubMed Web of Science ®Google Scholar
• Mcteague LM, Goodkind MS, Etkin A. Transdiagnostic impairment of cognitive control in mental illness. J Psychiatr Res. 2016;83:37–46.
   PubMed Web of Science ®Google Scholar
• Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions.Lancet. 2013;381(9878):1663–1671.
   Web of Science ®Google Scholar
• Han K, De Berardis D, Fornaro M, et al. Progress in neuropsychopharmacology & biological psychiatry differentiating between bipolar and unipolar depression in functional and structural MRI studies. Prog Neuropsychopharmacol Biol Psychiatry. 2019;91:20–27.
   PubMed Web of Science ®Google Scholar
• Ellard KK, Zimmerman JP, Kaur N, et al. Functional connectivity between anterior insula and key nodes of frontoparietal executive control and salience networks distinguish bipolar depression from unipolar depression and healthy controls. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(5):473–484.
   PubMedGoogle Scholar
• Basavaraju R, Sanjay TN, Mehta UM, et al. Cortical inhibition in symptomatic and remitted mania compared to healthy subjects : A cross- - sectional study. Bipolar Disord. 2017;00:1–6.
   Web of Science ®Google Scholar
• Chroni E, Lekka NP, Tsoussis I, et al. Effect of exercise on motor evoked potentials elicited by transcranial magnetic stimulation in psychiatric patients. J Clin Neurophysiol. 2002;19:240–244.
   PubMed Web of Science ®Google Scholar
• Levinson AJ, Frcp C, Young LT, et al. Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation. J Clin Psychopharmacol. 2007;27:493–497.
   PubMed Web of Science ®Google Scholar
• Ikuta T, Furuta N, Kihara S, et al. Differences in waveforms of cerebral evoked potentials among healthy subjects, schizophrenics, manic-depressives and epileptics. J Med Investig. 2007;54:303–315.
   PubMedGoogle Scholar
• Brocke B, John R. Sensation seeking and affective disorders : characteristics in the intensity dependence of. Neuropsychobiology. 2000;41:24–30.
   PubMed Web of Science ®Google Scholar
• Cabranes J, Ancin I, Santos J, et al. P50 sensory gating is a trait marker of the bipolar spectrum. Eur Neuropsychopharmacol. 2013;23:721–727.
   PubMed Web of Science ®Google Scholar
• Cabranes A, Santos L, Sa E, et al. No effect of polymorphisms in the non-duplicated region of the CHRNA7 gene on sensory gating P50 ratios in patients with schizophrenia and bipolar disorder. Psychiatry Res. 2013;205:276–278.
   PubMed Web of Science ®Google Scholar
• Schulze K, Hall M, Mcdonald C, et al. Auditory P300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disord. 2008;10:377–386.
   PubMed Web of Science ®Google Scholar
• Olincy A, Martin L. Diminished Suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry. 2005;162:43–49.
   PubMed Web of Science ®Google Scholar
• Schulze KK, Hall M, Mcdonald C, et al. P50 auditory evoked potential suppression in bipolar unaffected relatives. Biological Psychiatry. 2007;62(2):121-128.
   Google Scholar
• Patterson J, Sandman C, Ring A, et al. An initial report of a new biological marker for bipolar disorder : P85 evoked brain potential. Bipolar Disord. 2009;11:596–609.
   PubMed Web of Science ®Google Scholar
• Park Y, Lee S, Kim S, et al. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:313–316.
   PubMed Web of Science ®Google Scholar
• Yeap S, Kelly SP, Reilly RB, et al. Visual sensory processing deficits in patients with bipolar disorder revealed through high-density electrical mapping. J Psychiatry Neurosci. 2009;34:459–464.
   PubMed Web of Science ®Google Scholar
• Elvsåshagen T, Moberget T, Bøen E, et al. Evidence for impaired neocortical synaptic plasticity in bipolar II disorder. Biol Psychiatry. 2012;71:68–74.
   PubMed Web of Science ®Google Scholar
• Bestelmeyer PEG, Phillips LH, Crombie C, et al. The P300 as a possible endophenotype for schizophrenia and bipolar disorder : evidence from twin and patient studies. Psychiatry Res. 2009;169:212–219. Available from: http://dx.doi.org/10.1016/j.psychres.2008.06.035
   PubMed Web of Science ®Google Scholar
• Young AH, Hughes JH, Marsh VR, et al. Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder : a preliminary study. J Affect Disord. 2002;69:83–92.
   PubMed Web of Science ®Google Scholar
• Ziemann U, Lonnecker S, Steinhoff BJ, et al. Effects of antiepileptic drugs on motor cortex fxcitabilitv in humans : a transcranial magnetk stimulation study. Ann Neurol. 1996;40:367–378.
   PubMed Web of Science ®Google Scholar
• Ziemann U, Tergau F, Wischer S. Pharmacological control of facilitatory I-wave interaction in the human motor cortex . A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol. 1998;109:321–330.
   PubMedGoogle Scholar
• Li X, Ricci R, Large C, et al. Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm. 2009;116:423–429.
   PubMed Web of Science ®Google Scholar
• Heidegger T, Krakow K, Ziemann U. Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex. Eur J Neurosci. 2010;32:1215–1222.
   PubMed Web of Science ®Google Scholar
• Zunhammer M, Langguth B, Landgrebe M, et al. Modulation of human motor cortex excitability by valproate. Psychopharmacology (Berl). 2011;215:277–280.
   PubMed Web of Science ®Google Scholar
• Sommer M, Rummel M, Norden C, et al. Mechanisms of human motor cortex facilitation induced by subthreshold 5-Hz repetitive transcranial magnetic stimulation. J Neurophysiol. 2013;109:3060–3066.
   PubMed Web of Science ®Google Scholar
• Hübers A, Voytovych H, Heidegger T, et al. Acute effects of lithium on excitability of human motor cortex. Clin Neurophysiol. 2014;125:2240–2246.
   PubMed Web of Science ®Google Scholar
• Voytovych H, Kriváneková L, Ziemann U. Neuropharmacology lithium : aswitch from LTD- to LTP-like plasticity in human cortex. Neuropharmacol. 2012;63:274–279. Available from: http://dx.doi.org/10.1016/j.neuropharm.2012.03.023
   PubMed Web of Science ®Google Scholar
• Smith ME, Gevins A, Mcevoy LK, et al. Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate. Epilepsia. 2006;47:695–703.
   PubMed Web of Science ®Google Scholar
• Mecarelli O, Vicenzini E, Pulitano P. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacother. 2004;38(11):1816–1822.
   PubMed Web of Science ®Google Scholar
• Meyden Van Der CH, Bartel PR, Sommers DK, et al. Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function. Epilepsia. 1992;33:335–342.
   PubMed Web of Science ®Google Scholar
• Langguth B, Eichhammer P. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl). 2008;196:623–629.
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Saturno E, et al. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol. 2005;564:661–668.
   PubMed Web of Science ®Google Scholar
• Graham SJ, Langley RW, Verduzco AMB, et al. Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol. 2002;16:15–22.
   PubMed Web of Science ®Google Scholar
• Ziemann U, Tergau F, Bruns D, et al. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol. 1997;105:430–437.
   PubMedGoogle Scholar
• Meintzschel F, Ziemann U. Modification of practice-dependent plasticity in human motor cortex by neuromodulators. Cereb Cortex. 2006;16:1106–1115.
   PubMed Web of Science ®Google Scholar
• Abduljawad KAJ, Langley RW, Bradshaw CM, et al. Effects of bromocriptine and haloperidol on prepulse inhibition : comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. J Psychopharmacol. 1999;13:3–9.
   PubMed Web of Science ®Google Scholar
• Graham SJ, Langley RW, Bradshaw CM, et al. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. J Psychopharmacol. 2001;15:243–250.
   PubMed Web of Science ®Google Scholar
• Graham SJ, Scaife JC, Verduzco AMB, et al. Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol. 2004;18:173–180.
   PubMed Web of Science ®Google Scholar
• Lupi M, Martinotti G, Santacroce R, et al. Transcranial direct current stimulation in substance use disorders: a systematic review of scientific literature. J Ect. 2017;33:203–209.
   PubMed Web of Science ®Google Scholar
• Meron D, Hedger N, Garner M, et al. Transcranial direct current stimulation (tDCS) in the treatment of depression: systematic review and meta-analysis of efficacy and tolerability. Neurosci Biobehav Rev. 2015;57:46–62.
   PubMed Web of Science ®Google Scholar
• McClintock SM, Reti IM, Carpenter LL, et al. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry. 2019;79:1–32.
   Web of Science ®Google Scholar
• Pettorruso M, Spagnolo PA, Leggio L, et al. Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study. Brain Stimul. 2018;11(5):1195–1197.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GUYM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Bipolar Disorders : update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry. 2018;19(1):2–58.
   Google Scholar
• Bunse T, Wobrock T, Strube W, et al. Brain stimulation motor cortical excitability assessed by transcranial magnetic stimulation in psychiatric disorders : a systematic review. Brain Stimul. 2014;7:158–169. Available from: http://dx.doi.org/10.1016/j.brs.2013.08.009
   PubMed Web of Science ®Google Scholar
• George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry. 2011;168:356–364.
   PubMed Web of Science ®Google Scholar
• Bora E, Fornito A, Yücel M, et al. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry. 2010;67:1097–1105. Available from: http://dx.doi.org/10.1016/j.biopsych.2010.01.020
   PubMed Web of Science ®Google Scholar
• Kempton MJ, Salvador Z, Munafò MR, et al. Structural neuroimaging studies in major depressive disorder: meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry. 2011;68:675–690.
   PubMed Web of Science ®Google Scholar
• Forlenza OV, De-Paula VJR, Diniz BSO. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5:443–450.
   PubMed Web of Science ®Google Scholar
• Zhou K, Xie C, Wickström M, et al. Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brain. Oncotarget. 2017;8:34111–34127.
   PubMedGoogle Scholar
• Baldessarini R, Faedda G, Offidani E, et al. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord. 2013;148:129–135.
   PubMed Web of Science ®Google Scholar
• Tondo L, Vázquez G, Baldessarini R. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand. 2010;121:404–414.
   PubMed Web of Science ®Google Scholar
• Allain N, Leven C, Falissard B, et al. Manic switches induced by antidepressants : an umbrella review comparing randomized controlled trials and observational studies. Acta Psychiatr Scand. 2017;135(2):106–116.
   PubMed Web of Science ®Google Scholar
• Gould TD, Chen G, Manji HK. Mood stabilizer psychopharmacology Todd. Clin Neurosci Res. 2002;2:193–212.
   PubMedGoogle Scholar
• Young LT. What exactly is a mood stabilizer ? J Psychiatry Neurosci. 2004;29:87–88.
   PubMed Web of Science ®Google Scholar
• Yulug B, Hanoglu L, Tavli AM, et al. The brain protective effect of rTMS (Repetitive transcranial magnetic stimulation) in depression: a mini-review in animal studies. Med Chem. 2016;12:500–505.
   PubMed Web of Science ®Google Scholar
• Khodaie B, Saba V. The neuroprotective effects of long-term repetitive transcranial magnetic stimulation on the cortical spreading depression-induced damages in Rat’s Brain. Basic Clin Neurosci. 2018;9:87–100.
   PubMed Web of Science ®Google Scholar
• Otten M, Meeter M. Hippocampal structure and function in individuals with bipolar disorder: a systematic review. J Affect Disord. 2015;174:113–125.
   PubMed Web of Science ®Google Scholar
• Large CH, Di Daniel E, Li X, et al. Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine. Biochem Soc Trans. 2009;37:1080–1084.
   PubMed Web of Science ®Google Scholar